Özlem KUMAN TUNÇEL, Hüseyin Aytaç ERDEM, Hüsnü PULLUKÇU, Behice KURTARAN, Selin Ece TAŞBAKAN

COVID-19-related anxiety in people living with HIV: an online cross-sectional study

Background/aim: The emergence of the coronavirus disease 2019 (COVID-19) outbreak has had an enormous emotional impact on some vulnerable groups, such as people living with human immunodeficiency virus (HIV) (PLHIV). This study was planned with the aim of assessing the anxiety levels of PLHIV and the sources of their anxiety. Materials and methods: A web-based questionnaire was sent to PLHIV using the virtual snowball sampling method. The questionnaire included questions about sociodemographic status, information about HIV infection, and the Beck Anxiety Inventory (BAI). Additionally, some opinions of the participants about COVID-19 were asked. Results: A total of 307 respondents, with a median age of 33 years, from 32 different cities, participated in the study. More than half of the respondents reported the belief that COVID-19 was not sufficiently well-known by the medical community and nearly 45% believed that they would have more complications if they contracted COVID-19. One-fourth of the participants had anxiety. Having a preexisting psychiatric disorder, perceiving that they were practicing insufficient preventive measures, not being sure about the presence of any individuals with COVID-19 in their environment, and living with a household member with a chronic disease were found to be the risk factors of PLHIV for having anxiety during this pandemic. The BAI scores were correlated with the patient-reported anxiety levels about the spread of COVID-19 in Turkey, acquiring COVID-19, transmitting COVID-19 to another person, and transmitting HIV to another person. Among the stated conditions, the most common concern was the spread of COVID-19 all over the country, while the least common was transmitting HIV to someone else. Conclusion: The results revealed that a significant proportion of the sample had anxiety, and the findings were essential for developing evidence-based strategies for decreasing the anxiety of PLHIV, especially for those who had risk factors and to provide them with better health care during this pandemic or other pandemic-like crises.

PDF

___

1. Zhu N, Zhang D, Wang W, Li X, Yang B et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine 2020; 382 (8): 727-733. doi: 10.1056/ NEJMoa2001017
2. Demirbilek Y, Pehlivantürk G, Özgüler ZO, Alp Meşe E. COVID-19 outbreak control, example of ministry of health of Turkey. Turkish Journal of Medical Sciences 2020; 50(SI-1): 489- 494. doi:10.3906/sag-2004-187
3. Koçak Tufan Z, Kayaaslan B. Crushing the curve, the role of national and international institutions and policy makers in COVID-19 pandemic. Turkish Journal of Medical Sciences 2020; 50(SI-1): 495-508. doi:10.3906/sag-2004-167
4. Çiftçi E, Çoksüer F. Novel Coronavirus Infection: COVID-19. Flora the Journal of Infectious Diseases and Clinical Microbiology 2020; 25 (1): 9-18.
5. Zhu F, Cao Y, Xu S, Zhou M. Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China. Journal of Medical Virology 2020. doi:10.1002/jmv.25732
6. Nutho B, Mahalapbutr P, Hengphasatporn K, Pattaranggoon NC, Simanon N et al. Why are lopinavir and ritonavir effective against the newly emerged Coronavirus 2019? Atomistic insights into the inhibitory mechanisms. Biochemistry 2020. doi:10.1021/acs. biochem.0c00160
7. Ford N, Vitoria M, Rangaraj A, Norris SL, Calmy A et al. Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment. Journal of International AIDS Society 2020; 23 (4): e25489. doi:10.1002/ jia2.25489
8. Joob B, Wiwanitkit V. SARS-CoV-2 and HIV. Journal of Medical Virology 2020. doi:10.1002/jmv.25782
9. Chen J, Cheng X, Wang R, Zeng X. Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19). Journal of Medical Virology 2020. doi:10.1002/ jmv.25879
10. Blanco JL, Ambrosioni J, Garcia F, Martinez E, Soriano A et al. COVID-19 in patients with HIV: clinical case series. Lancet HIV 2020. doi:10.1016/S2352-3018(20)30111-9
11. Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. HIV/SARS-CoV-2 coinfected patients in Istanbul, Turkey. Journal of Medical Virology 2020. doi:10.1002/jmv.25955
12. Vizcarra P, Perez-Elias MJ, Quereda C, Moreno A, Vivancos MJ et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV 2020. doi:10.1016/ S2352-3018(20)30164-8
13. Lima CKT, Carvalho PMM, Lima I, Nunes J, Saraiva JS et al. The emotional impact of Coronavirus 2019-nCoV (new Coronavirus disease). Psychiatry Research 2020; 287: 112915. doi:10.1016/j. psychres.2020.112915
14. Guo W, Weng HL, Bai H, Liu J, Wei XN et al. [Quick community survey on the impact of COVID-19 outbreak for the healthcare of people living with HIV]. Zhonghua Liu Xing Bing Xue Za Zhi 2020, 41 (5): 663-667. doi:10.3760/cma.j.cn112338-20200314-00345
15. Sun S, Hou J, Chen Y, Lu Y, Brown L et al. Challenges to HIV Care and Psychological Health During the COVID-19 Pandemic Among People Living with HIV in China. AIDS and Behavior 2020. doi:10.1007/s10461-020-02903-4
16. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology 1988, 56 (6): 893-897. doi:10.1037//0022-006x.56.6.893
17. Beck AT, Steer RA. Beck Anxiety Inventory Manual. San Antonio, TX: Psychological Corporation; 1993.
18. Ulusoy M, Hisli-Sahin N, Erkmen H. Turkish Version of the Beck Anxiety Inventory: Psychometric Properties. Journal of Cognitive Psychotherapy 1998; 12 (2): 163-172.
19. Yildiz Sevgi D, Gunduz A, Altuntas Aydin O, Mete B, Sargin F et al. Adherence to Antiretroviral Therapy in Turkey: Results from the ACTHIV-IST Study Group. AIDS Research and Human Retroviruses 2017; 33 (12): 1192-1198. doi:10.1089/ AID.2016.0266
20. Zhang D, Bi P, Hiller JE, Lv F. Web-based HIV/AIDS behavioral surveillance among men who have sex with men: potential and challenges. International Journal of Infectious Diseases 2008; 12 (2): 126-131. doi:10.1016/j.ijid.2007.06.007
21. Richman WL, Weisband S, Kiesler S, Drasgow F. A metaanalytic study of social disability distortion in computeradministered questionnaires, traditional questionnaires, and interviews. Journal of Applied Psychology 1999; 84: 754-755. doi:10.1037/0021-9010.84.5.754
22. Taha S, Matheson K, Cronin T, Anisman H. Intolerance of uncertainty, appraisals, coping, and anxiety: the case of the 2009 H1N1 pandemic. British Journal of Health Psychology 2014; 19 (3): 592-605. doi:10.1111/bjhp.12058
23. Ceylan E, Koç A, İnkaya AC, Ünal S. Determination of medication adherence and related factors among people living with HIV/AIDS in a Turkish university hospital. Turkish Journal of Medical Sciences 2019; 49 (1): 198-205.doi:10.3906/ sag-1802-137
24. Adepoju P. Tuberculosis and HIV responses threatened by COVID-19. Lancet HIV 2020. doi:10.1016/S2352- 3018(20)30109-0
25. Carrico AW, Horvath KJ, Grov C, Moskowitz JT, Pahwa S et al. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19. AIDS and Behavior 2020. doi:10.1007/ s10461-020-02854-w
26. Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN. The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective. AIDS and Behavior 2020. doi:10.1007/s10461- 020-02871-9
27. Mascolo S, Romanelli A, Carleo MA, Esposito V. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better. Journal of Medical Virology 2020. doi:10.1002/jmv.25881
28. Chew QH, Wei KC, Vasoo S, Chua HC, Sim K. Narrative synthesis of psychological and coping responses towards emerging infectious disease outbreaks in the general population: practical considerations for the COVID-19 pandemic. Singapore Medical Journal 2020. doi:10.11622/ smedj.2020046
29. Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. Lancet HIV 2020. doi:10.1016/S2352- 3018(20)30105-3
30. Algarin AB, Varas-Rodriguez E, Valdivia C, Fennie KP, Larkey L et al. Symptoms, Stress, and HIV-Related Care Among Older People Living with HIV During the COVID-19 Pandemic, Miami, Florida. AIDS and Behavior 2020. doi:10.1007/s10461- 020-02869-3
31. Pantelic M, Shenderovich Y, Cluver L, Boyes M. Predictors of internalised HIV-related stigma: a systematic review of studies in sub-Saharan Africa. Health Psychology Review 2015; 9(4): 469-490. doi:10.1080/17437199.2014.996243
32. Grupe DW, Nitschke JB. Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nature Reviews Neuroscience 2013; 14 (7): 488- 501. doi:10.1038/nrn3524
33. Buchbinder SP, Liu AY. CROI 2019: advances in HIV prevention and plans to end the epidemic. Topics in Antiviral Medicine 2019; 27 (1): 8-25.
34. Mok E, Chung BP, Chung JW, Wong TK. An exploratory study of nurses suffering from severe acute respiratory syndrome (SARS). International Journal of Nursing Practice 2005; 11(4):150-160. doi:10.1111/j.1440-172X.2005.00520.x
35. Chan SS, Leung D, Chui H, Tiwari AF, Wong EM et al. Parental response to child’s isolation during the SARS outbreak. Ambulatory Pediatrics 2007; 7 (5): 401-404. doi:10.1016/j. ambp.2007.06.002
36. Siu JY, Sung HC, Lee WL. Qigong practice among chronically ill patients during the SARS outbreak. Journal of Clinical Nursing 2007; 16 (4): 769-776. doi:10.1111/j.1365-2702.2006.01695.x